TRPM2 and acute myeloid leukemia: Taken together, these results suggest that TRPM2 plays a leading role in AML; given that it contributes to AML survival, doxorubicin sensitivity, and myeloid cell differentiation, it can represent a promising target for innovative therapeutic strategy in AML.